Interindividual variability in expression and activity of human β- glucuronidase in liver and kidney: Consequences for drug metabolism

Journal of Pharmacology and Experimental Therapeutics

Volumn 281, Issue 2, 1997, Pages 914-920

  Sperker, Bernhard ^b   Mürdter, Thomas E ^b   Schick, Monika ^b   Eckhardt, Klaus ^b   Bosslet, Klaus ^b   Kroemer, Heyo K ^a  

^a DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLUCURONIDASE; DOXORUBICIN; ESTRADIOL; GLUCURONIDE; GLYCYRRHIZIC ACID; HYMECROMONE GLUCURONIDE; N (4 BETA GLUCURONYL 3 NITRO BENZYLOXY CARBONYL)DOXORUBICIN; N (4 BETA GLUCURONYL 3 NITROBENZYLOXYCARBONYL)DOXORUBICIN; PARACETAMOL GLUCURONIDE; UNCLASSIFIED DRUG;

ARTICLE; COMPETITIVE INHIBITION; DRUG GLUCURONIDATION; DRUG METABOLISM; ENZYME KINETICS; HUMAN; HUMAN TISSUE; KIDNEY; LIVER; MICHAELIS CONSTANT; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; FEMALE; GLUCURONIDASE; HUMANS; HYMECROMONE; KIDNEY; KINETICS; LIVER; MALE; MIDDLE AGED;

EID: 8244245267     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. ABE, N., EBINA, T. AND ISHIDA, N.: Interferon induction by glycyrrhizin and glycyrrhetinic acid in mice. Microbiol. Immunol. 26: 535-539, 1982.
2. BOSSLET, K., CZECH, J. AND HOFFMANN, D.: Tumor-selective prodrug activation by fusion protein-mediated catalysis. Cancer Res. 54: 2151-2159, 1994.
3. BOSSLET, K., CZECH, J., LORENZ, P., SEDLACEK, H. H., SCHUERMANN, M. AND SEEMANN, G.: Molecular and functional characterisation of a fusion protein suited for tumor specific prodrug activation. Br. J. Cancer 65: 234-238, 1992.
4. BRATER, D. C.: Clinical pharmacology of NSAIDs. J. Clin. Pharmacol. 28: 518-523, 1988.
5. BROT, F. E., BELL, C. E. AND SLY, W. S.: Purification and properties of β-glucuronidase from human placenta. Biochemistry 17: 385-391, 1978.
6. BRUNELLE, F. M. AND VERBEECK, R. K.: Glucuronidation of diflunisal by rat liver microsomes: Effect of microsomal β-glucuronidase activity. Biochem. Pharmacol. 46: 1953-1958, 1993.
7. BRUNELLE, F. M. AND VERBEECK, R. K.: Glucuronidation of diflunisal in liver and kidney microsomes of rat and man. Xenobiotica 26: 123-131, 1996.
8. CAMISA, C., HESSEL, A., ROSSANA, C. AND PARKS, A.: Autosomal dominant keratoderma, ichthyosiform dermatosis and elevated serum β-glucuronidase. Dermatologica 177: 341-347, 1988.
9. CHABAS, A., GIROS, M. L. AND GUARDIOLA, A.: Low β-glucuronidase activity in a healthy member of a family with mucopolysaccharidosis VII. J. Inher. Metab. Dis. 14: 908-914, 1991.
10. CORRALES-HERNANDEZ, J. J., GONZALEZ-BUITRAGO, J. M., PASTOR-ENCINAS, I., GARCIA-DIEZ, L. C. AND MIRALLES, J. M.: Androgen environment and β-glucuronidase activity in the human kidney. Arch. Androl. 20: 185-191, 1988.
11. ERICKSON, A. H. AND BLOBEL, G.: Carboxyl-terminal proteolytic processing during biosynthesis of the lysosomal enzymes β-glucuronidase and cathepsin D. Biochemistry 22: 5201-5205, 1983.
12. ERIKSSON, L.-O., WÄHLIN-BOLL, E., ODAR-CEDERLÖF, I., LINDHOLM, L. AND MELANDER, A.: Influence of renal failure, rheumatoid arthritis and old age on the pharmacokinetics of diflunisal. Eur. J. Clin. Pharmacol. 36: 165-174, 1989.
13. FISHMAN, W. H. AND ANLYAN, A. J.: The presence of high β-glucuronidase activity in cancer tissue. J. Biol. Chem. 169: 449-450, 1947.
14. FISHMAN, W. H., KATO, K., ANSTISS, C. L. AND GREEN, S.: Human serum β-glucuronidase: Its measurement and some of its properties. Clin. Chim. Acta 15: 435-447, 1967.
15. FROMM, M. F., BOTSCH, S., HEINKELE, G., EVERS, J. AND KROEMER, H. K.: Influence of renal function on the steady-state pharmacokinetics of the antiarrhythmic propafenone and its Phase I and Phase II metabolites. Eur. J. Clin. Pharmacol. 48: 279-283, 1995.
16. GEHRMANN, M. C., OPPER, M., SEDLACEK, H. H., BOSSLET, K. AND CZECH, J.: Biochemical properties of recombinant human β-glucuronidase synthesized in baby hamster kidney cells. Biochem. J. 301: 821-828, 1994.
17. HENLE, K. J., MONSON, T. P., NAGLE, W. A. AND MOSS, A. J.: Tumor-targeted cell killing with 8-hydroxyquinolyl-glucuronide. Radiation Res. 115: 373-386, 1988.
18. HERMAN, R. J., VAN PHAM, J. D. AND SZAKACS, C. B. N.: Disposition of lorazepam in human beings: Enterohepatic recirculation and first-pass effect. Clin. Pharmacol. Ther. 46: 18-25, 1989.
19. JACQUESY, J.-C., GESSON, J.-P., MONNERET, C., MONDON, M., RENOUX, B., FLORENT, J.-C., KOCH, M., TILLEQUIN, F., SEDLACEK, H. H., KOLAR, C. AND GAUDEL, G.: Prodrogues glycosylées, leur procédé de préparation et leurs utilisation. Demande de Brevet Européen, EP 0 511 917 A1, 1992.
20. JOHNSON, E. F. AND SCHWAB, G. E.: Constitutive forms of rabbit-liver microsomal cytochrome P-450: Enzymatic diversity, polymorphism and allosteric regulation. Xenobiotica 14: 3-18, 1984.
21. KANAOKA, M., YANO, S., KATO, H. AND NAKADA, T.: Synthesis and separation of 18β-glycyrrhetyl monoglucuronide from serum of a patient with glycyrrhizin-induced pseudo-aldosteronism. Chem. Pharm. Bull. 34: 4978-4983, 1986.
22. KORNFELD, S.: Structure and function of the mannose 6-phosphate/insulin-like growth factor II receptors. Ann. Rev. Biochem. 61: 307-330, 1992.
23. KROEMER, H. K. AND KLOTZ, U.: Glucuronidation of drugs: A re-evaluation of the pharmacological significance of the conjugates and modulating factors. Clin. Pharmacokinet. 23(4): 292-310, 1992.
24. KUMAGAI, A., YANO, M., OTOMO, M. AND TAKEUCHI, K.: Study on the corticoid-like action of glycyrrhizin and mechanism of its action. Endocrinol. Jpn. 4: 17-27, 1957.
25. LIEBERMAN, J. A., COOPER, T. B., SUCKOW, R. F., STEINBERG, H., BORENSTEIN, M., BRENNER, R. AND KANE, J. M.: Tricyclic antidepressant and metabolite levels in chronic renal failure. Clin. Pharmacol. Ther. 37: 301-307, 1985.
26. LOWRY, O. H., ROSEBROUGH, N. J., FARR, A. L. AND RANDALL, R. J.: Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275, 1951.
27. MEDDA, S. AND SWANK, R. T.: Egasyn, a protein which determined the subcellular distribution of β-glucuronidase, has esterase activity. J. Biol. Chem. 260: 15802-15808, 1985.
28. MEFFIN, P. J., ZILM, D. M. AND VEENENDAAL, J. R.: Reduced clofibric acid clearance in renal dysfunction is due to a futile cycle. J. Pharmacol. Exp. Ther. 227: 732-738, 1983.
29. OHTA, H., MINORU, O., SEKIYA, C. AND MASAYOSHI, N.: Serum immunoreactive β-glucuronidase determined by an enzyme-linked immunosorbent assay in patients with hepatic diseases. Clin. Chim. Acta. 208: 9-21, 1992.
30. OSBORNE, R. J., JOEL, S. P. AND SLEVIN, M. L.: Analgesic activity of morphine-6-glucuronide. Lancet 1: 828, 1988.
31. PAIGEN, K.: Mammalian β-glucuronidase: Genetics, molecular biology and cell biology. Prog. Nucleic Acid Res. Mol. Biol. 37: 155-205, 1989.
32. POMPEI, R., FLORE, O., MARCCIALIS, M. A., PANI, A. AND LODDO, B.: Glycyrrhizic acid inhibits virus growth and inactivates virus particles. Nature (Lond.) 281: 689-690, 1979.
33. SAHA, A. K., GLEW, R. H., KOTLER, D. P. AND OMENE, J. A.: Elevated serum β-glucuronidase activity in acquired immunodeficiency syndrome. Clin. Chim. Acta 199: 311-316, 1991.
34. SHIPLEY, J. M., GRUBB, J. H. AND SLY, W. S.: The role of glycosylation and phosphorylation in the expression of active human β-glucuronidase. J. Biol. Chem. 268: 12193-12198, 1993.
35. SLY, W. S., QUINTON, B. A., MCALISTER, W. H. AND RIMOIN, D. L.: Beta glucuronidase deficiency: Report of clinical, radiologic and biochemical features of a new mucopolysaccharidosis. J. Pediatr. 82: 249-257, 1973.
36. SPERKER, B., HU, P.-C. AND HERRMANN, R.: Identification of gene products of the P 1 operon of Mycoplasma pneumoniae. Mol. Microbiol. 5: 299-306, 1991.
37. SPERKER, B., SCHICK, M. AND KROEMER, H. K.: High-performance liquid chromatographic quantification of 4-methylumbelliferyl-β-D-glucuronide as a probe for human β-glucuronidase in tissue homogenates. J. Chromatogr. B 685: 181-184, 1996.
38. SUTFIN, T. A., PERINI, G. I., MOLNAR, G. AND JUSKO, W. J.: Multiple-dose pharmacokinetics of imipramine and its major active and conjugated metabolites in depressed patients. J. Clin. Psychopharmacol. 8: 48-53, 1988.
39. SWANK, R. T., PAIGEN, K., DAVEY, R., CHAPMAN, V., LABARCA, C., WATSON, G., GANSCHOW, R., BRANDT, E. J. AND NOVAK, E.: Genetic regulation of mammalian glucuronidase. Recent Prog. Horm. Res. 34: 401-436, 1978.
40. SZASZ, G.: Serum β-glucuronidase determination with p-nitrophenyl-glucuronide. Clin. Chim. Acta 15: 275-282, 1967.
41. TOMINO, S. AND PAIGEN, K.: Egasyn, a protein complexed with microsomal β-glucuronidase. J. Biol. Chem. 250: 1146-1148, 1975.
42. WALLE, T., CONRADI, E. C., WALLE, U. K., GRAFFNEY, T. E.: Propranolol glucuronide accumulation during long-term therapy: A proposed storage mechanism for propranolol. Clin. Pharmacol. Ther. 26: 686-695, 1979.
43. WHITING, J. F., NARCISO, J. P., CHAPMAN, V., RANSIL, B. J., SWANK, R. T. AND GOLLAN, J. L.: Deconjugation of Bilirubin-IXα glucuronides: A physiologie role of hepatic microsomal β-glucuronidase. J. Biol. Chem. 268: 23197-23201, 1993.